Skip to content

Survey of response to co- treatment of single dose fluconazole with vaginal lactobacillus in diabetic patients with vaginal candidiasis

Assessing the response to co- treatment of single dose fluconazole with vaginal lactobacillus in diabetic patients with vaginal candidiasis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180612040071N1
Enrollment
130
Registered
2018-08-16
Start date
2019-09-06
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candidal Vulvovaginitis. Candidiasis of vulva and vagina

Interventions

Intervention 1: intervention group: Oral single dose Fluconazol (150mg) treatment with vaginal Lacto Flora Fem for 14 nights. Intervention 2: Control group: : Oral single dose Fluconazol (150mg) treat

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: married women aged 18-45 years old non pregnant diabetic no diagnosed medical disease such as auto immune diseases, by asking the patient diagnosis of candidal vulvovaginitis by clinical symptoms, positive KOH test and cultivation absence of menstruation at the time of attendance not using vaginal medications, antibiotics , immonosupressive drugs and exogenous hormones such as oral contraceptives since 2 weeks before starting the research not having intercourse or using vaginal douche within the last 24 hours

Exclusion criteria

Exclusion criteria: allergic reactions to fluconazole or lacto flora fem pregnancy during therapy use antibiotics or other anti fungal drugs

Design outcomes

Primary

MeasureTime frame
Vaginal candidiasis symptoms. Timepoint: 1 month (30dayes ) after the use of probiotics or placebo. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Nazeri

Kashan University of Medical Sciences

nazeri_me@kaums.ac.ir+98 31 5554 1112

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026